{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:01:36Z","timestamp":1786118496430,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1097\/01.mph.0000134463.09543.99","type":"journal-article","created":{"date-parts":[[2004,7,28]],"date-time":"2004-07-28T04:01:54Z","timestamp":1090987314000},"page":"497-503","source":"Crossref","is-referenced-by-count":24,"title":["Persistent Human Parvovirus B19 Infection in Children Under Maintenance Chemotherapy for Acute Lymphocytic Leukemia"],"prefix":"10.1097","volume":"26","author":[{"given":"Sarah","family":"Fattet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Cassinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja Beck","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210227","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(75)91074-0","article-title":"Parvovirus-like particles in human sera.","volume":"i","author":"Cossart","year":"1975","journal-title":"Lancet"},{"key":"R2-7-20210227","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/bmj.311.7019.1549","article-title":"Parvovirus B19: an expanding spectrum of disease.","volume":"311","author":"Cohen","year":"1995","journal-title":"Br Med J"},{"key":"R3-7-20210227","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0065-3101(24)00033-1","article-title":"Parvovirus infections in children and adults.","volume":"46","author":"Cherry","year":"1999","journal-title":"Adv Pediatr"},{"key":"R4-7-20210227","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s100249900128","article-title":"Parvovirus B19: twenty-five years in perspective.","volume":"2","author":"Rogers","year":"1999","journal-title":"Pediatr Dev Pathol"},{"key":"R5-7-20210227","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/CMR.15.3.485-505.2002","article-title":"Human parvovirus B19.","volume":"15","author":"Heegaart","year":"2002","journal-title":"Clin Microbiol Rew"},{"key":"R6-7-20210227","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1537-2995.2001.41010130.x","article-title":"Parvovirus B19: implications for transfusion medicine. Summary of a workshop.","volume":"41","author":"Brown","year":"2001","journal-title":"Transfusion"},{"key":"R7-7-20210227","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0950268899003817","article-title":"The age-specific prevalence of human parvovirus immunity in Victoria, Australia, compared with other parts of the world.","volume":"124","author":"Kelly","year":"2000","journal-title":"Epidemiol Infect"},{"key":"R8-7-20210227","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/infdis\/152.2.257","article-title":"Experimental parvovirus infection in man.","volume":"152","author":"Anderson","year":"1985","journal-title":"J Infect Dis"},{"key":"R9-7-20210227","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1172\/JCI112978","article-title":"Variation of erythroid and myeloid precursors in the bone marrow and the peripheral blood of volunteer subjects infected with human parvovirus (B19).","volume":"79","author":"Potter","year":"1987","journal-title":"J Clin Invest"},{"key":"R10-7-20210227","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1034\/j.1399-0012.1999.t01-1-130103.x","article-title":"Human parvovirus B19 infection in organ transplant recipients.","volume":"13","author":"Marchand","year":"1999","journal-title":"Clin Transplant"},{"key":"R11-7-20210227","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1034\/j.1399-0012.2000.140612.x","article-title":"Pure red cell aplasia caused by parvovirus B19 infection in solid organ transplant recipients: a case report and review of the literature.","volume":"14","author":"Geetha","year":"2000","journal-title":"Clin Transplant"},{"key":"R12-7-20210227","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/JCM.40.11.3909-3912.2002","article-title":"Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple course of chemotherapy.","volume":"40","author":"Kuo","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R13-7-20210227","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000204365","article-title":"Retrospective study on the influence of human parvovirus B19 infection among children with malignant diseases.","volume":"90","author":"Yoto","year":"1993","journal-title":"Acta Haematol"},{"key":"R14-7-20210227","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-911X(199808)31:2<66::AID-MPO4>3.0.CO;2-X","article-title":"Persistent B19 parvovirus infection in pediatric malignances.","volume":"31","author":"Broliden","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"R15-7-20210227","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2141.2000.02407.x","article-title":"Parvovirus B19 transmitted by bone marrow.","volume":"111","author":"Heegaard","year":"2000","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"R16-7-20210227","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/cei.1996.104.s1.26","article-title":"Parvovirus infection and its treatment.","volume":"104","author":"Young","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"R17-7-20210227","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/000992288802700806","article-title":"Severe anemia caused by human parvovirus in a leukaemia patient on maintenance chemotherapy.","volume":"27","author":"Smith","year":"1988","journal-title":"Clin Pediatr"},{"key":"R18-7-20210227","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00043426-200106000-00015","article-title":"Parvovirus B19 infection in a child with acute lymphocytic leukaemia during induction therapy.","volume":"23","author":"McNall","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"R19-7-20210227","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ajh.2830500317","article-title":"Pancytopenia secondary to parvovirus B19 infection in a child with acute lymphocytic leukemia, mimicking leukemia relapse.","volume":"50","author":"Smith","year":"1995","journal-title":"Am J Hematol"},{"key":"R20-7-20210227","first-page":"85","article-title":"Parvovirus infection in a child with acute lymphocytic leukemia.","volume":"84","author":"Alberti","year":"1999","journal-title":"Haematologica"},{"key":"R21-7-20210227","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/088800199277155","article-title":"The role of parvovirus B19 infection in childhood acute lymphoblastic leukemia.","volume":"16","author":"Heegaart","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"R22-7-20210227","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2141.2003.03983_3.x","article-title":"Parvovirus B19 infection and acute lymphoblastic leukaemia.","volume":"120","author":"Savasan","year":"2003","journal-title":"Br J Haematol"},{"key":"R23-7-20210227","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00043426-200206000-00009","article-title":"Serologic study on parvovirus B19 infection in childhood acute lymphocytic leukemia during chemotherapy: clinical and hematological implications.","volume":"24","author":"Heegaart","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"R24-7-20210227","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s004300050063","article-title":"Persistent parvovirus B19 infections in immunocompromised children.","volume":"186","author":"Flunker","year":"1998","journal-title":"Med Microbiol Immunol"},{"key":"R25-7-20210227","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/00365549509047066","article-title":"Parvovirus B19 infection: persistence and genetic variation.","volume":"27","author":"Kerr","year":"1995","journal-title":"Scand J Infect Dis"},{"key":"R26-7-20210227","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0140-6736(95)90850-1","article-title":"Persistent parvovirus B19 infection.","volume":"345","author":"Kerr","year":"1995","journal-title":"Lancet"},{"key":"R27-7-20210227","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/(SICI)1096-9071(199711)53:3<229::AID-JMV8>3.0.CO;2-A","article-title":"Evidence for persistence of human parvovirus B19 DNA in bone marrow.","volume":"53","author":"Cassinotti","year":"1997","journal-title":"J Med Virol"},{"key":"R28-7-20210227","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s100960000384","article-title":"Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual.","volume":"19","author":"Cassinotti","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R29-7-20210227","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1572-0241.1998.468_1.x","article-title":"Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: a report of two cases and a review of the literature.","volume":"93","author":"Pardi","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R30-7-20210227","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/S0140-6736(98)06165-0","article-title":"Acute parvovirus B19 infection associated with fulminant hepatitis of favorable prognosis in young children.","volume":"352","author":"Sokal","year":"1998","journal-title":"Lancet"},{"key":"R31-7-20210227","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(05)76124-9","article-title":"Parvovirus B19 infection and fulminant hepatitis.","volume":"353","author":"Bernuau","year":"1999","journal-title":"Lancet"},{"key":"R32-7-20210227","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/ndt\/15.9.1486","article-title":"Parvovirus B19-related acute hepatitis in an immunosuppressed kidney transplant.","volume":"15","author":"Lee","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R33-7-20210227","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0022-3476(05)82820-3","article-title":"Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients.","volume":"116","author":"Koch","year":"1990","journal-title":"J Pediatr"},{"key":"R34-7-20210227","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s002770050315","article-title":"Red cell aplasia caused by parvovirus B19 in AIDS: use of IV immunoglobulin.","volume":"75","author":"Koduri","year":"1997","journal-title":"Ann Hematol"},{"key":"R35-7-20210227","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<16::AID-AJH4>3.0.CO;2-Y","article-title":"Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulina report of eight patients.","volume":"61","author":"Koduri","year":"1999","journal-title":"Am J Hematol"},{"key":"R36-7-20210227","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/CMR.13.4.602","article-title":"Passive immunity in prevention and treatment of infectious diseases.","volume":"13","author":"Keller","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"R37-7-20210227","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5414\/CNP59311","article-title":"Successful treatment of chronic parvovirus B19 infection by high-dose immunoglobulin.","volume":"59","author":"Mareschal-Desandes","year":"2003","journal-title":"Clin Nephrol"},{"key":"R38-7-20210227","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7326\/0003-4819-113-12-926","article-title":"Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia with AIDS.","volume":"113","author":"Frickhofen","year":"1990","journal-title":"Ann Intern Med"},{"key":"R39-7-20210227","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jmv.10452","article-title":"Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases.","volume":"71","author":"Gallinella","year":"2003","journal-title":"J Med Virol"},{"key":"R40-7-20210227","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1086\/368382","article-title":"Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1.","volume":"187","author":"Ballou","year":"2003","journal-title":"J Infect Dis"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mph.0000134463.09543.99","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:11:50Z","timestamp":1786032710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200408000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mph.0000134463.09543.99","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}